Appropriate Selection of PARP Inhibitors in Ovarian Cancer
Maria Smith, Bhavana Pothuri
Topics & Concepts
MedicinePARP inhibitorOlaparibBevacizumabOvarian cancerOncologyInternal medicineBRCA mutationMaintenance therapyClinical trialChemotherapyCancerPoly ADP ribose polymerasePolymeraseBiochemistryChemistryGenePARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer